Provided by Tiger Trade Technology Pte. Ltd.

Secondary Listings on HKEX

448.194
-8.884-1.94%
Number of Gainers:2
Number of Losers:17
Number of Flat:- -
PE:- -
High:456.994
Open:456.994
Low:444.254
Close:457.078
Volume:161.53M
Turnover:15.37B
Market Cap:4.61T
Float Cap:4.47T

Loading ...

XPENG-W Delivers 39,107 Vehicles in August, Marking a 4% Year-on-Year Growth

Stock News
·
Sep 01

ZTO Express-W Allocates $4.99 Million to Buy Back 234,200 Shares on August 31

Stock News
·
Sep 01

Li Auto Boosts Deliveries and Unveils New Flagship EVs Amid Network Expansion

TIPRANKS
·
Sep 01

Fitch Assigns H World First-Time Rating of BBB; Outlook Stable

MT Newswires Live
·
Sep 01

Hong Kong Market Morning Bell: Hang Seng Opens Lower as Tech and AI Stocks Slip

Stock News
·
Sep 01

Baidu Completes Conversion to Dual Primary Listing in Hong Kong and on Nasdaq

TIPRANKS
·
Sep 01

Baidu Shifts Hong Kong Listing to Dual-Primary from Secondary Listing

Reuters
·
Sep 01

BeiGene Expands Access to Innovative Cancer Therapy Through New U.S. Agreement

Stock News
·
Sep 01

Li Auto Files HKEX Next-Day Disclosure Return on Share Buyback at HKD 47.81 Each

Reuters
·
Aug 31

Jefferies Adjusts XPeng's Price Target to HK$75.70 From HK$98.30, Keeps at Buy

MT Newswires Live
·
Aug 31

HarmonyOS Beta Arrives: NetEase Music Rolls Out Early Access for Huawei Users

Deep News
·
Aug 31

Inflation Concerns Cap Cryptocurrency Recovery as Markets Reassess Rate Outlook

Deep News
·
Aug 31

Hong Kong Stocks Edge Lower on Monday Amid Middle East Tensions; HUTCHMED Falls 2%

MT Newswires Live
·
Aug 31

Hutchmed Says Savolitinib Plus AstraZeneca’s Tagrisso Extends PFS in China Phase III Sanovo Lung Cancer Trial

Reuters
·
Aug 31

Yum China Files HKEX Next-Day Disclosure Return on Share Repurchase Cancellation

Reuters
·
Aug 31

HUTCHMED Sees Positive High Level Results in Lung Cancer Drug Combo Trial

MT Newswires Live
·
Aug 31

ZTO Express-W Allocates $4.995 Million for Share Buyback on August 28

Stock News
·
Aug 31

Hutchmed (China) - Announces Positive Results from Sanovo China Phase Trial in Nsclc Patients

THOMSON REUTERS
·
Aug 31

Hutchmed Announces Sanovo Trial Demonstrated Significant Progression-Free Survival Benefit of Orpathys® Plus Tagrisso® in Treatment-NaÏVe Patients with Met-Overexpressing Egfr-Mutated Lung Cancer in China

THOMSON REUTERS
·
Aug 31

Autohome (ATHM) Completes $243.6 Million In Share Buybacks Across Two Tranches

Simply Wall St.
·
Aug 31